New lens option may reduce need for glasses after cataract surgery in glaucoma patients

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Patients of any sex aged 18 years or older willing to participate and sign the informed consent form. * Clinically significant cataracts in both eyes. * Patients clinically diagnosed of primary open angle glaucoma (POAG) in both eyes. * Early to moderate POAG, as defined by a mean deviation in the Humphrey Visual Field Analyzer (HFA) no worse than ≤ -12 dB and worse ≥ -2 dB at least in one eye, using a 24-2 SITA standard strategy * Two visual field tests without progression and stability of RNFL in Optical Coherence Tomography (OCT) thickness remaining same or less than 10 um in the previous 6 months, with pharmacologically controlled IOP in both eyes \<21mmHg. * Potential for post-surgery monocular distance corrected visual acuity of ≤ 0.10 LogMAR. * Normal corneal topography. * Able to attend all study visits. Exclusion criteria: * Patients with uncontrolled glaucoma, defined as those with an IOP ≥21 mm Hg despite maximal medical therapy, requiring glaucoma surgery and/or laser in either eye in the next year. * Pre-surgery refractive error requiring IOL implantation beyond the commercially available range. * Patients with a not reliable visual field, a VFI ≤ 60% or defects of ≤ 10 dB in the 4 central points of the visual field. Any other form of glaucoma (pseudoexfoliative, severe forms of pigmentary, primary angle closure glaucoma, etc.), ocular hypertension, zonular instability or possible intuitive lens decentration after surgery. * Patients with any previous glaucoma surgery or any other ocular surgery that can affect the results, or any ocular surgery in the previous six months. * Any other ocular pathology that can affect the results. * Use of topic or systemic medication that may affect vision * Unable to cooperate to obtain consistent testing results. * Participation in any other trial during or within 30 days of the screening visit.